Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization

BACKGROUND: Safety after the second dose of the SARS-CoV-2 vaccine remains to be elucidated, especially among individuals reporting adverse events after their first dose. This study aims to evaluate the impact of a delayed second dose on all-cause mortality and emergency services. METHODS: A territo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Carlos King Ho, Xiong, Xi, Lau, Kristy Tsz Kwan, Chui, Celine Sze Ling, Lai, Francisco Tsz Tsun, Li, Xue, Chan, Esther Wai Yin, Wan, Eric Yuk Fai, Au, Ivan Chi Ho, Cowling, Benjamin John, Lee, Cheuk Kwong, Wong, Ian Chi Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926447/
https://www.ncbi.nlm.nih.gov/pubmed/35296305
http://dx.doi.org/10.1186/s12916-022-02321-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926447/
https://www.ncbi.nlm.nih.gov/pubmed/35296305
http://dx.doi.org/10.1186/s12916-022-02321-4

Ejemplares similares